Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan
· Delayed Price · Currency is TWD 67.90
+0.70 (1.04%)
Apr 24, 2025, 1:30 PM CST
TPEX:4747 Revenue
In the year 2024, Johnson Chemical Pharmaceutical Works had annual revenue of 611.42M TWD with 0.78% growth. Johnson Chemical Pharmaceutical Works had revenue of 147.82M in the quarter ending December 31, 2024, a decrease of -4.47%.
Revenue
611.42M
Revenue Growth
+0.78%
P/S Ratio
4.99
Revenue / Employee
3.58M
Employees
171
Market Cap
3.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 611.42M | 4.70M | 0.78% |
| Dec 31, 2023 | 606.71M | 112.04M | 22.65% |
| Dec 31, 2022 | 494.67M | 83.18M | 20.21% |
| Dec 31, 2021 | 411.49M | -12.52M | -2.95% |
| Dec 31, 2020 | 424.02M | -1.32M | -0.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |